These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21131835)

  • 1. COX-2 expression in nonepithelial ovarian malignancies.
    Menczer J; Schreiber L; Sukmanov O; Czernobilsky B; Berger E; Golan A; Levi T
    Int J Gynecol Pathol; 2011 Jan; 30(1):41-5. PubMed ID: 21131835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Her-2/neu expressed in nonepithelial ovarian malignancies?
    Menczer J; Schreiber L; Czernobilsky B; Berger E; Golan A; Levy T
    Am J Obstet Gynecol; 2007 Jan; 196(1):79.e1-4. PubMed ID: 17240244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokeratin and CD30 expression in dysgerminoma.
    Cossu-Rocca P; Jones TD; Roth LM; Eble JN; Zheng W; Karim FW; Cheng L
    Hum Pathol; 2006 Aug; 37(8):1015-21. PubMed ID: 16867864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of p53 is not a feature of ovarian granulosa cell tumors.
    Liu FS; Ho ES; Lai CR; Chen JT; Shih RT; Yang CH; Tsao CM
    Gynecol Oncol; 1996 Apr; 61(1):50-3. PubMed ID: 8626117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.
    Cheng L; Zhang S; Talerman A; Roth LM
    Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor alpha and progesterone receptor expression in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors.
    Farinola MA; Gown AM; Judson K; Ronnett BM; Barry TS; Movahedi-Lankarani S; Vang R
    Int J Gynecol Pathol; 2007 Oct; 26(4):375-82. PubMed ID: 17885486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cox-2 expression in ovarian malignancies: a review of the clinical aspects.
    Menczer J
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):129-32. PubMed ID: 19559517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant ovarian tumors in childhood].
    Zucker JM
    Bull Cancer; 1982; 69(3):304-13. PubMed ID: 6181838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary nonepithelial cancers of the ovary.
    Cavanagh D; Marsden DE; Ruffolo EH
    Obstet Gynecol Annu; 1985; 14():344-81. PubMed ID: 2984613
    [No Abstract]   [Full Text] [Related]  

  • 11. OCT4: a novel biomarker for dysgerminoma of the ovary.
    Cheng L; Thomas A; Roth LM; Zheng W; Michael H; Karim FW
    Am J Surg Pathol; 2004 Oct; 28(10):1341-6. PubMed ID: 15371950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 expression in borderline ovarian tumors.
    Ferrandina G; Zannoni GF; Ranelletti FO; Legge F; Gessi M; Salutari V; Gallotta V; Lauriola L; Scambia G
    Gynecol Oncol; 2004 Oct; 95(1):46-51. PubMed ID: 15385109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histochemistry of hormonally active ovarian tumors.
    Kedzia H; Pisarski T
    Pol Med Sci Hist Bull (1973); 1975; 15(2):229-39. PubMed ID: 177958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of p53 expression in immature teratomas.
    Charoenkwan P; Senger C; Weitzman S; Sexsmith E; Sherman CG; Malkin D; Thorner PS
    Pediatr Dev Pathol; 2002; 5(5):499-507. PubMed ID: 12202994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue.
    Gurusinghe CJ; Healy DL; Jobling T; Mamers P; Burger HG
    Gynecol Oncol; 1995 Apr; 57(1):27-32. PubMed ID: 7705698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of glial cell line-derived neurotropic factor receptor alpha-1 in immature teratomas.
    Bing Z; Pasha TL; Lal P; Tomaszewski JE
    Am J Clin Pathol; 2008 Dec; 130(6):892-6. PubMed ID: 19019765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation potential of ovarian dysgerminoma: an immunohistochemical study of 15 cases.
    Lifschitz-Mercer B; Walt H; Kushnir I; Jacob N; Diener PA; Moll R; Czernobilsky B
    Hum Pathol; 1995 Jan; 26(1):62-6. PubMed ID: 7821917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors.
    Cathro HP; Stoler MH
    Hum Pathol; 2005 Feb; 36(2):195-201. PubMed ID: 15754297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD56 expression in ovarian granulosa cell tumors, and its diagnostic utility and pitfalls.
    Ohishi Y; Kaku T; Oya M; Kobayashi H; Wake N; Tsuneyoshi M
    Gynecol Oncol; 2007 Oct; 107(1):30-8. PubMed ID: 17583777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
    Grischke EM; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.